Alamar Biosciences (ALMR) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Alamar Biosciences reported total assets of $139.99M and total liabilities of $298.95M. Shareholders' equity was negative at −$158.95M, meaning liabilities exceed assets. Total debt stood at $41.47M against $30.00M in cash and short-term investments, a net debt position of $11.47M.

Alamar Biosciences Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Alamar Biosciences, Inc. (ALMR) - Annual data in millions USD
Breakdown	FY 2025	FY 2024
Period ending	Dec 2025	Dec 2024
Current Assets
Cash and Cash Equivalents	30.00	26.77
Short-Term Investments	0.00	52.59
Cash & Short-Term Investments	30.00	79.36
Accounts Receivable	12.75	6.65
Inventory	38.48	14.41
Other Current Assets	13.47	5.61
Total Current Assets	94.71	106.70
Non-Current Assets
Property, Plant & Equipment (Net)	36.63	35.10
Intangible Assets	1.99	2.04
Other Non-Current Assets	6.67	5.67
Total Non-Current Assets	45.29	42.81
Total Assets	139.99	149.51
Current Liabilities
Accounts Payable	5.87	6.19
Short-Term Debt	2.10	-
Accrued Liabilities	7.70	2.50
Deferred Revenue	0.47	0.58
Other Current Liabilities	15.29	0.56
Total Current Liabilities	23.73	16.59
Non-Current Liabilities
Long-Term Debt	39.37	31.19
Other Non-Current Liabilities	235.84	0.15
Total Non-Current Liabilities	275.22	266.33
Total Liabilities	298.95	282.92
Stockholders' Equity
Common Stock	0.00	0.00
Retained Earnings	-168.78	-138.96
Accumulated Other Comprehensive Income	-0.07	0.15
Additional Paid-in Capital	9.89	5.40
Shares Outstanding	66.52	66.52
Total Stockholders' Equity	-158.95	-133.41
Total Liabilities & Equity	139.99	149.51

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Alamar Biosciences Balance Sheet

How much debt does Alamar Biosciences have?

Alamar Biosciences had total debt of $41.47M as of Dec 31, 2025, against $30.00M in cash and short-term investments. Total debt was $31.19M a year earlier.

What are Alamar Biosciences's total assets?

Alamar Biosciences reported total assets of $139.99M as of Dec 31, 2025, down 6.4% from $149.51M a year earlier. Total liabilities were $298.95M.

What is Alamar Biosciences's shareholders' equity?

Alamar Biosciences's shareholders' equity was negative at −$158.95M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition